Acute myocardial infarction (AMI) seriously threatens human life. In this study we aimed to systemically analyze the function of key gene modules in human platelets in AMI. We used weighted gene co-expression network analysis (WGCNA) to construct a co-expression module, and analyzed the relationship between potential modules and clinical characteristics based on platelet RNA-seq RPKM count reads of 16 ST-segment elevation myocardial infarction (STEMI) patients and 16 non-STEMI (NSTEMI) patients provided by the GEO database.
Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed with the DAVID tool. Hub genes were calculated by the Cytohubba package. A total of 3653 genes was selected to construct the co-expression modules.
A significant correlation between BMI and the module with color of sky-blue in STEMI. In NSTEMI, there was a significant correlation between the sky blue module and CAD, the Salmon module and HT, and the Cyan module and HT. In STEMI, the Hub genes were mainly enriched in functions related to cell membrane signal transduction including Aqp1, Armcx1, Gsta4, Hist3h2a and Il17re.
In NSTEMI, the Hub genes are related mainly to energy metabolism in the sky-blue module including Olr1, Nap1l3, Gfer, Dohh, Crispld1 and Ccdc8b; they are mainly related to extracellular space and calcium binding in the Cyan module, including Clec12b, Chd4, Asgr1, Armcx4, Chid1 and Alkbh7.
The hub genes in the Salmon module include Ell3, Aldh1b1, Cavin4, Cabp4, Eif1ay and Dus3l. Our results provide a framework for co-expression gene modules in STEMI and NSTEMI patients, and identify key targets as biomarkers for patients with different subtypes of AMI.
Reproducibility and sensitivity of 36 methods to quantify the SARS-CoV-2 genetic signal in raw wastewater: findings from an interlaboratory methods evaluation in the U.S
In response to COVID-19, the international water community rapidly developed methods to quantify the SARS-CoV-2 genetic signal in untreated wastewater. Wastewater surveillance using such methods has the potential to complement clinical testing in assessing community health. This interlaboratory assessment evaluated the reproducibility and sensitivity of 36 standard operating procedures (SOPs), divided into eight method groups based on sample concentration approach and whether solids were removed.
Two raw wastewater samples were collected in August 2020, amended with a matrix spike (betacoronavirus OC43), and distributed to 32 laboratories across the U.S. Replicate samples analyzed in accordance with the project’s quality assurance plan showed high reproducibility across the 36 SOPs: 80% of the recovery-corrected results fell within a band of ±1.15 log10 genome copies per L with higher reproducibility observed within a single SOP (standard deviation of 0.13 log10).
The inclusion of a solids removal step and the selection of a concentration method did not show a clear, systematic impact on the recovery-corrected results. Other methodological variations (e.g., pasteurization, primer set selection, and use of RT-qPCR or RT-dPCR platforms) generally resulted in small differences compared to other sources of variability.
These findings suggest that a variety of methods are capable of producing reproducible results, though the same SOP or laboratory should be selected to track SARS-CoV-2 trends at a given facility. The methods showed a 7 log10 range of recovery efficiency and limit of detection highlighting the importance of recovery correction and the need to consider method sensitivity when selecting methods for wastewater surveillance.
stjosephs-hospital
ExTraMapper: Exon- and Transcript-level mappings for orthologous gene pairs
Motivation: Access to large-scale genomics and transcriptomics data from various tissues and cell lines allowed the discovery of wide-spread alternative splicing events and alternative promoter usage in mammalians. Between human and mouse, gene-level orthology is currently present for nearly 16k protein-coding genes spanning a diverse repertoire of over 200k total transcript isoforms.
Results: Here, we describe a novel method, ExTraMapper, which leverages sequence conservation between exons of a pair of organisms and identifies a fine-scale orthology mapping at the exon and then transcript level. ExTraMapper identifies more than 350k exon mappings, as well as 30k transcript mappings between human and mouse using only sequence and gene annotation information.
We demonstrate that ExTraMapper identifies a larger number of exon and transcript mappings compared to previous methods. Further, it identifies exon fusions, splits, and losses due to splice site mutations, and finds mappings between microexons that are previously missed.
By reanalysis of RNA-seq data from 13 matched human and mouse tissues, we show that ExTraMapper improves the correlation of transcript-specific expression levels suggesting a more accurate mapping of human and mouse transcripts. We also applied the method to detect conserved exon and transcript pairs between human and rhesus macaque genomes to highlight the point that ExTraMapper is applicable to any pair of organisms that have orthologous gene pairs.
Availability: The source code and the results are available
Unconventional viral gene expression mechanisms as therapeutic targets
Unlike the human genome that comprises mostly noncoding and regulatory sequences, viruses have evolved under the constraints of maintaining a small genome size while expanding the efficiency of their coding and regulatory sequences.
As a result, viruses use strategies of transcription and translation in which one or more of the steps in the conventional gene-protein production line are altered. These alternative strategies of viral gene expression (also known as gene recoding) can be uniquely brought about by dedicated viral enzymes or by co-opting host factors (known as host dependencies).
Targeting these unique enzymatic activities and host factors exposes vulnerabilities of a virus and provides a paradigm for the design of novel antiviral therapies. In this Review, we describe the types and mechanisms of unconventional gene and protein expression in viruses, and provide a perspective on how future basic mechanistic work could inform translational efforts that are aimed at viral eradication.
anti- GCNF antibody |
FNab03390 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against GCNF |
GCNF Conjugated Antibody |
C48479 |
SAB |
100ul |
EUR 476.4 |
Germ Cell Nuclear Factor (GCNF) Antibody |
20-abx131389 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
-
100 ug
-
10 ug
-
1 mg
-
200 ug
-
50 ug
|
|
Germ Cell Nuclear Factor (GCNF) Antibody |
abx131389-02mg |
Abbexa |
0.2 mg |
EUR 337.5 |
Germ Cell Nuclear Factor (GCNF) Antibody |
abx131389-05mg |
Abbexa |
0.5 mg |
EUR 750 |
Germ Cell Nuclear Factor (GCNF) Antibody |
abx131389-100g |
Abbexa |
100 µg |
EUR 275 |
GCNF |
E8EM1710-12 |
EnoGene |
100ul |
EUR 275 |
Description: Available in various conjugation types. |
Polyclonal NR6A1 / GCNF Antibody (Ligand-binding Domain) |
AMM06820G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NR6A1 / GCNF (Ligand-binding Domain). This antibody is tested and proven to work in the following applications: |
GCNF (anti human nuclear recepter antibody, clone# H7921) |
PP-H7921-00 |
Sceti |
0.1mg/100uL |
EUR 747.6 |
Description: The GCNF (anti human nuclear recepter antibody, clone# H7921) is available in Europe and for worldwide shipping via Gentaur. |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody |
CAU24184-100ul |
Biomatik Corporation |
100ul |
EUR 235.2 |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody |
CAU24184-200ul |
Biomatik Corporation |
200ul |
EUR 294 |
Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
PAC509Hu01 |
Cloud-Clone |
100ul |
EUR 245 |
|
GCNF Mouse mAb |
E2220732 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human) |
4-PAC509Hu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF) |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), PE |
4-PAC509Hu01-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with PE. |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), APC |
4-PAC509Hu01-APC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with APC. |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), Cy3 |
4-PAC509Hu01-Cy3 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with Cy3. |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), HRP |
4-PAC509Hu01-HRP |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with HRP. |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), FITC |
4-PAC509Hu01-FITC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with FITC. |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), Biotinylated |
4-PAC509Hu01-Biotin |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with Biotin. |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), APC-Cy7 |
4-PAC509Hu01-APC-Cy7 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with APC-Cy7. |
Recombinant Germ Cell Nuclear Factor (GCNF) |
RPC509Hu01 |
Cloud-Clone |
10ug |
EUR 164 |
Recombinant Germ Cell Nuclear Factor (GCNF) |
4-RPC509Hu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
-
100 ug
-
10ug
-
1 mg
-
200 ug
-
500 ug
-
50ug
-
5 mg
|
|
Description: Recombinant Human Germ Cell Nuclear Factor expressed in: E.coli |
Human Germ Cell Nuclear Factor (GCNF) Protein |
20-abx650014 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
-
100 ug
-
10 ug
-
1 mg
-
200 ug
-
50 ug
|
|
Human Germ Cell Nuclear Factor (GCNF) Protein |
abx650014-100g |
Abbexa |
100 µg |
EUR 212.5 |
Human Germ Cell Nuclear Factor (GCNF) Protein |
abx650014-200g |
Abbexa |
200 µg |
EUR 375 |
anti-GCNF |
YF-PA11986 |
Abfrontier |
50 ul |
EUR 435.6 |
Description: Mouse polyclonal to GCNF |
anti-GCNF |
YF-PA11987 |
Abfrontier |
50 ug |
EUR 435.6 |
Description: Mouse polyclonal to GCNF |
anti-GCNF |
YF-PA11988 |
Abfrontier |
100 ul |
EUR 483.6 |
Description: Rabbit polyclonal to GCNF |
anti-GCNF |
YF-PA11989 |
Abfrontier |
100 ug |
EUR 483.6 |
Description: Rabbit polyclonal to GCNF |
anti-GCNF |
YF-PA23769 |
Abfrontier |
50 ul |
EUR 400.8 |
Description: Mouse polyclonal to GCNF |
Anti-KAT2A / GCN5 (3F8) |
YF-MA10372 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to KAT2A / GCN5 |
Anti-KAT2A / GCN5 (4F9) |
YF-MA13213 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to KAT2A / GCN5 |
GCN5 (GCN5) Antibody |
abx233389-100ug |
Abbexa |
100 ug |
EUR 610.8 |
|
GCN5 (GCN5) Antibody |
20-abx007509 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
GCN5 Antibody |
F40091-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: GCN5 functions as a histone acetyltransferase (HAT) to promote transcriptional activation. Acetylation of histones gives a specific tag for epigenetic transcription activation. This protein has significant histone acetyltransferase activity with core histones, but not with nucleosome core particles. |
GCN5 Antibody |
F40091-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
|
Description: GCN5 functions as a histone acetyltransferase (HAT) to promote transcriptional activation. Acetylation of histones gives a specific tag for epigenetic transcription activation. This protein has significant histone acetyltransferase activity with core histones, but not with nucleosome core particles. |
GCN5 Antibody |
F41987-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: KAT2A, or GCN5, is a histone acetyltransferase (HAT) that functions primarily as a transcriptional activator. It also functions as a repressor of NF-kappa-B by promoting ubiquitination of the NF-kappa-B subunit RELA in a HAT-independent manner. |
GCN5 Antibody |
F41987-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
|
Description: KAT2A, or GCN5, is a histone acetyltransferase (HAT) that functions primarily as a transcriptional activator. It also functions as a repressor of NF-kappa-B by promoting ubiquitination of the NF-kappa-B subunit RELA in a HAT-independent manner. |
GCN2 Antibody |
F50133-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
|
Description: GCN2 (EIF2AK4) belongs to a family of kinases that phosphorylate the alpha subunit of eukaryotic translation initiation factor-2 to downregulate protein synthesis in response to varied cellular stresses. |
GCN2 Antibody |
49575 |
SAB |
100ul |
EUR 499 |
GCN2 Antibody |
49575-100ul |
SAB |
100ul |
EUR 399.6 |
GCN2 Antibody |
49575-50ul |
SAB |
50ul |
EUR 286.8 |
GCN5 antibody |
70R-51548 |
Fitzgerald |
100 ul |
EUR 242 |
|
Description: Purified Polyclonal GCN5 antibody |
GCN2 Antibody |
R31137 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: Eukaryotic Translation Initiation Factor 2-Alpha Kinase 4, also called GCN2 (General control nonderepressible 2), is an enzyme that in humans is encoded by the EIF2AK4 gene. It belongs to a family of kinases that phosphorylate the alpha subunit of eukaryotic translation initiation factor-2 to downregulate protein synthesis in response to varied cellular stresses. Hartz(2005) mapped the gene to chromosome 15q15.1 based on an alignment of the protein sequence with the genomic sequence. Berlanga et al.(1999) demonstrated that GCN2 immunopurified from mouse liver extracts could phosphorylate rabbit Eif2 in vitro. Serum starvation increased the level of phosphorylated EIF2-alpha more than 2-fold in human embryonic kidney cells transfected with mouse Eif2ak4. Costa-Mattioli et al.(2005) reported a unique feature of hippocampal slices from GCN2-null mice: in CA1, a single 100-Hz train induced a strong and sustained long-term potentiation(late LTP or L-LTP), which was dependent on transcription and translation. |
GCN5L2 antibody |
10R-1171 |
Fitzgerald |
100 ul |
EUR 320 |
|
Description: Mouse monoclonal GCN5L2 antibody |
GCN5L2 antibody |
10R-1647 |
Fitzgerald |
100 ug |
EUR 614.4 |
Description: Mouse monoclonal GCN5L2 antibody |
GCN5L2 Antibody |
E19-3383 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
GCN5L2 Antibody |
E11-11438C |
EnoGene |
100μg |
EUR 225 |
Description: Available in various conjugation types. |
GCN5L2 Antibody |
E92224 |
EnoGene |
100μg |
EUR 255 |
Description: Available in various conjugation types. |